Analyst Report: FIS
1. EXECUTIVE SUMMARY
FIS fell 23.67% on Wednesday 4 November 2026 to $29.76, its lowest close in the table and a new 52-week low, after the company cut full-year 2026 guidance and announced the exit of its CFO in the same pre-market release. Q3 itself was a small beat, so the reaction came from the outlook: Raymond James, as reported by Investing.com, said preliminary 2027 guidance points to nearly flat revenue and an adjusted EPS decline in the high-single to low-double digits, well below consensus growth. JPMorgan and William Blair downgraded the shares, and Raymond James cut its target while keeping an Outperform rating. Volume reached 37,084,500 shares, 5.97x the 50-session average, and the S&P 500 rose 1.58% that day, so the sell-off belongs to the company. The stock now trades on a forward P/E of 4.5, which prices in a continued earnings decline and leaves open how much of the 2027 reset the market has already absorbed.
2. THE CATALYST
Q3 results and the CFO departure were released together before the open on 4 November (FIS press release; Benzinga). The brief identifies no event that explains the earlier gains on 30 October and 2 November.
Guidance cut. According to the FIS press release, the company now expects full-year 2026:
- Adjusted EPS growth of 1.2% to 2.4%, with adjusted EPS of $5.82 to $5.89
- Adjusted EBITDA growth of 29% to 30%
- Pro forma revenue growth of 3.1% to 3.6%, with revenue of $13,445M to $13,505M
MarketScreener (headline only) put the FactSet revenue estimate at $13.66B, which sits above the new range. Raymond James said management cut its 2026 adjusted EPS outlook by about 6%. JPMorgan called it a second consecutive full-year EPS cut, led by a weaker Banking unit because of client-led conversion delays and consolidation (TradingView/Seeking Alpha).
Q3 against expectations.
| Metric | Reported | Expected | Source |
|---|---|---|---|
| Adjusted EPS | $1.61 | $1.60 | Investing.com |
| Revenue | $3.45B | $3.43B | Investing.com |
AskTraders says adjusted EPS matched the average of 12 analysts, which disagrees with Investing.com on whether there was a beat. The gap is $0.01 either way.
2027 and capital allocation. Raymond James, via Investing.com, said preliminary 2027 guidance points to nearly flat revenue and an adjusted EPS decline in the high-single to low-double digits, against consensus growth of 4% in revenue and 7% in EPS. The brief could not check this against the company's own 2027 commentary. Management said it has curtailed buybacks and paused tuck-in M&A to speed up deleveraging, with Q3 buybacks at $21M (FIS press release).
CFO exit. James Kehoe steps down effective 5 November, and Alexandra Brooks becomes interim CFO (Benzinga). AskTraders called the CFO change the main trigger, while Investing.com, JPMorgan and the Motley Fool put the guidance cut first. The weight of sources favours the guidance cut.
Analyst reactions.
| Firm | Action | Source |
|---|---|---|
| JPMorgan | Downgraded to Neutral from Overweight; target $38 from $53 | Seeking Alpha |
| Raymond James | Target $35 from $50; Outperform maintained | Investing.com |
| William Blair | Downgraded to Market Perform from Outperform, citing decelerating revenue growth and limited visibility | Investing.com |
Investing.com also reported 21 negative EPS revisions from analysts in the 90 days before the report. Expectations were already lowered, which is inference-friendly evidence that the stock had little room for disappointment.
3. COMPANY PROFILE
Fidelity National Information Services provides solutions to financial institutions, businesses and developers. It reports through Banking Solutions, Capital Market Solutions, and Corporate and Other. Its products cover core processing, mobile and online banking, fraud and compliance, card and retail payments, wealth and retirement, and trading and lending. It sits in the Technology sector under Information Technology Services, with a market cap of $15.38bn. Peers in transaction and payment processing include Visa, Mastercard, PayPal, Block (XYZ), Fiserv (FISV) and Global Payments.
Q3 results from the FIS press release:
- GAAP diluted EPS of $0.69 and adjusted EPS of $1.61, up 6.6%
- Free cash flow of $862M, up 8%
- Pro forma recurring revenue growth of 2.5% and Banking Solutions pro forma revenue growth of 3.9%
- Debt of $20.8B at 30 September 2026 (the Motley Fool cites net debt above $14B, a different measure)
On the earnings call (Investing.com transcript), management said client-led implementation delays, lower non-recurring revenue and higher cybersecurity spending will weigh on results, and professional services revenue fell 20%. Benzinga reported that license revenue from 2026 strategic distribution agreements will not recur in 2027, and that 72% of Total Issuing Solutions revenue is contracted through 2029 and beyond. The company affirmed a $0.44 quarterly dividend payable in late December (Yahoo/Simply Wall St, summary only). The company also sold a non-core prepaid business for over $100M, announced 20 October (FIS press release).
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The Q3 quarter was clean, with growth in adjusted EPS and free cash flow. The sell-off stems from the forward path: a second consecutive full-year EPS cut, a 2027 outlook that Raymond James places well below consensus, a non-recurring license revenue gap in 2027, and a leverage priority that suspends buybacks and tuck-in M&A. A CFO leaving on the day of a guidance cut adds uncertainty about the credibility of the new numbers. A one-day fall of 23.67% is large relative to the Q3 beat, but the reset in 2027 expectations is the larger factor, and the move brings the stock to a year-to-date decline of 53.20%.
Peers. Over the same period Visa rose 3.84%, Mastercard 3.94%, PayPal 3.42%, Block 15.30% and Fiserv 6.25%, while Global Payments fell 1.95%. The brief found no sector driver, and Investing.com attributed the decline to company-specific factors. The brief could not open the Trefis piece on Fiserv, so the reason for that peer's rise is unknown.
Comparable episode. Raymond James cut its target from $95 to $88 after Q2 results on margin guidance, and the shares fell about 8% (Investing.com). The article carries no exact date, roughly 15 months back by its age metadata, so the timing should be verified. AskTraders called 4 November the steepest one-day drop in 126 sessions.
Bull case.
- A forward P/E of 4.5 and a dividend yield of 4.51% price in a severe earnings decline.
- Free cash flow grew 8% in Q3, and deleveraging should allow buybacks to resume at about 2.8x gross leverage (FIS press release).
- Contracted Issuing revenue offers some visibility (Benzinga).
- Management expects to provide an update on strategic alternatives in early 2027 (Benzinga), which could create a catalyst.
- Raymond James kept an Outperform rating with a $35 target, above the close.
Bear case.
- Two consecutive annual EPS cuts reduce trust in guidance.
- William Blair cites limited visibility for improvement, and JPMorgan points to Banking unit weakness from conversion delays and consolidation.
- Heavy debt and a halt to buybacks limit capital returns.
- The CFO is leaving at the point the outlook worsens.
- The consensus target of $47.96 (MarketBeat) rests on pre-move targets and sits well above the close, so further target cuts are likely (inference).
Wells Fargo reportedly cut to Equal Weight with a $46 target, but the brief could not confirm the date of that note. Truist cut its target to $37 from $43 on 23 October, before the results (dailypolitical.com, mirroring MarketBeat), with moderate confidence in the source.
5. TECHNICAL SNAPSHOT
The $29.76 close is the lowest in the table, so no support level is visible in the recent closes, and the intraday low of $29.15 doubles as the 52-week low. The price sits below the 50-day average of $36.59 and the 200-day average of $42.58, and it is 55.1% below the 52-week high of $66.26 set on 8 January. The nearest resistance in the closes is $35.61 from 27 October, with $38.99, the pre-results close, above that. Volume of 37,084,500 shares, 5.97x the 50-session average, shows heavy repositioning. Volume had already risen on 30 October (13,725,200) and 3 November (12,245,900) before the report.
6. RISK FACTORS
- Execution. Client-led implementation delays and consolidation in the Banking unit are the stated drivers of the cut, and they can persist.
- Guidance credibility. A second consecutive cut and a CFO transition raise the odds of further revisions (inference).
- Leverage. Debt of $20.8B limits flexibility while buybacks and M&A are curtailed.
- 2027 earnings. The Raymond James read of a high-single to low-double digit EPS decline remains unverified against company commentary.
- Legal noise. A law-firm investigation notice from Levi & Korsinsky (PR Newswire, 5 November) is a solicitation and not a regulatory action. The brief did not open it.
Dated events:
- 5 November 2026: CFO departure takes effect, with Alexandra Brooks as interim CFO.
- Late December 2026: $0.44 quarterly dividend payable.
- Early 2027: management update on strategic alternatives.
- The facts list 4 November as the next earnings date, which is the quarter just reported. The brief found no sourced date for the next report.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). The stock sits at a 52-week low after a volume spike. Further analyst target cuts and the CFO handover will drive headlines. A move back toward $35.61 would need evidence that the 2027 reset is smaller than Raymond James describes; further revisions or CFO-related news would pressure the shares toward and below the $29.15 low.
Medium term (1-3 months). Direction depends on the naming of a permanent CFO, any detail on 2027 guidance, and progress on conversions in Banking. The strategic alternatives update is due in early 2027, which falls at the edge of this window.
Long term. The thesis has changed. Growth expectations for 2027 have been cut, capital returns are suspended until gross leverage reaches about 2.8x, and management credibility has weakened. A forward P/E of 4.5 and a 4.51% yield offer valuation support. The case for recovery rests on deleveraging, cash flow growth and the outcome of the strategic review. This is analysis, not personal financial advice.